44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma

Clinical Nuclear Medicine
Ambreen KhawarRalph A Bundschuh

Abstract

[Sc]Sc-PSMA-617 with 3.9-hour half-life, in vitro and in vivo characteristics similar to [Lu]Lu-PSMA-617 and possibility of delayed imaging after 24 hours or later, implies it to be advantageous than [ Ga]Ga-PSMA-617 for pretherapeutic dosimetric assessment for [Lu]Lu-PSMA-617 in metastatic castration-resistant prostate carcinoma (mCRPC) patients. In this study, we investigated biodistribution and radiation exposure to normal organs with [Sc]Sc-PSMA-617 in mCRPC patients. Five mCRPC patients (mean age, 69 years) enrolled for [Lu]Lu-PSMA-617 therapy were injected with 40-62 MBq [Sc]Sc-PSMA-617 intravenously; Siemens Biograph 2 PET/CT system was used to acquire dynamic PET data (30 minutes) in list mode over the abdomen, followed by the collection of static PET/CT images (skull to mid-thigh) at 45 minutes, 2 and approximately 20 hours postinjection. Time-dependent changes in percentage activity in source organs (kidneys, bladder, salivary glands, small intestine, liver, spleen, and whole body) were determined. Bone marrow and urinary bladder contents residence time were also calculated. Source organs residence time, organ-absorbed doses, and effective doses were determined using OLINDA/EXM software. Physiological tracer uptake wa...Continue Reading

References

Oct 1, 2010·Current Oncology·S J Hotte, F Saad
Nov 2, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ying ChenMartin G Pomper
Apr 3, 2012·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Marek PruszyńskiFrank Roesch
Apr 24, 2012·Clinics·Fernando C MalufDaniel Herchenhorn
Apr 18, 2013·Current Topics in Medicinal Chemistry·Ronnie C MeaseMartin G Pomper
Mar 1, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Christian M ZechmannUwe Haberkorn
Oct 25, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Shankar VallabhajosulaStanley J Goldsmith
Feb 28, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sangeeta Ray BanerjeeMartin G Pomper
Apr 18, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Martina BenešováMatthias Eder
Apr 18, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ken HerrmannMichael Lassmann
Apr 22, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Zsolt SzaboMartin G Pomper
Jun 20, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Martina WeineisenHans-Jürgen Wester
Aug 22, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ali Afshar-OromiehUwe Haberkorn
Sep 1, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Andreas DelkerGuido Böning
Sep 17, 2015·European Journal of Nuclear Medicine and Molecular Imaging·A PfestroffUNKNOWN Radionuclide Therapy Committee of the European Association of Nuclear Medicine
Oct 11, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Felix M MottaghyFrederik A Verburg
Jan 13, 2016·European Journal of Nuclear Medicine and Molecular Imaging·C SachpekidisA Dimitrakopoulou-Strauss
Jan 23, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard P BaumHans-Jürgen Wester
Apr 9, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kambiz RahbarHojjat Ahmadzadehfar
May 7, 2016·Nuclear Medicine and Biology·Tapas DasSharmila Banerjee
May 22, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Christian H PfobMatthias Eiber
Jun 5, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Ali Afshar-OromiehUwe Haberkorn
Oct 25, 2016·Nuclear Medicine and Biology·Maroor Raghavan Ambikalmajan PillaiFurn F Russ Knapp
Sep 24, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Shozo OkamotoMatthias Eiber
Oct 30, 2016·Expert Review of Molecular Diagnostics·Martin BarrioKen Herrmann
Oct 4, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ali Afshar-OromiehUwe Haberkorn
Oct 4, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Harshad R KulkarniRichard P Baum
Oct 22, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kambiz RahbarBernd Joachim Krause
Mar 25, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Anna YordanovaHojjat Ahmadzadehfar
May 11, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Hojjat AhmadzadehfarMarkus Essler

❮ Previous
Next ❯

Citations

Oct 30, 2019·EJNMMI Radiopharmacy and Chemistry·Jean-Philippe SinnesFrank Rösch
Mar 14, 2020·EJNMMI Physics·Florian RosarMathias Schreckenberger
Sep 10, 2020·Nuclear Medicine and Biology·Heinz H Coenen, Johannes Ermert
Jan 31, 2021·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Florian RosarAndrea Schaefer-Schuler
Apr 2, 2021·ChemMedChem·Natalia Herrero ÁlvarezJason S Lewis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.